Provided by Tiger Trade Technology Pte. Ltd.

Gilead Sciences

147.68
+1.380.94%
Pre-market: 147.56-0.1200-0.08%06:45 EDT
Volume:5.19M
Turnover:767.00M
Market Cap:183.22B
PE:-56.47
High:149.30
Open:146.58
Low:146.12
Close:146.30
52wk High:157.29
52wk Low:108.46
Shares:1.24B
Float Shares:1.24B
Volume Ratio:1.07
T/O Rate:0.42%
Dividend:3.22
Dividend Rate:2.18%
EPS(TTM):-2.6150
EPS(LYR):6.78
ROE:-20.68%
ROA:14.09%
PB:15.49
PE(LYR):21.78

Loading ...

GSK Notifies Availability of Viiv Healthcare AIDS 2026 Data Presentation Announcement

Reuters
·
Jul 21

Gilead : Leerink Partners Cuts to Market Perform from Outperform; Cuts Target Price to $127 from $146

THOMSON REUTERS
·
Jul 21

Moderna Inc. Stock Slides 3.8%, Underperforms Peers

Dow Jones
·
Jul 21

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Jul 18

Gilead’s Zamzetoclax Trial Update: What a Terminated Phase 1 Means for GILD Investors

TIPRANKS
·
Jul 18

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-07-17

Reuters
·
Jul 17

Is Gilead Sciences (GILD) Fully Valued Following Mixed Earnings And A Full Year EPS Miss?

Simply Wall St.
·
Jul 17

Gilead Chief Comm & Corp Aff Officer Johanna Mercier Sells 3,000 Shares for $389,757.60

Reuters
·
Jul 17

Moderna Inc. Stock Sheds 7.5%, Underperforms Peers

Dow Jones
·
Jul 17

Movement Alert|Gilead Sciences Rises 3.02% in Regular Trading, Lifted by Broad Biotech Sector Strength

Market Focus
·
Jul 17

Gilead Targets Long-Acting HIV Regimens With New Injectable Study

TIPRANKS
·
Jul 17

Kalshi to Allow Bets on Clinical Trials, FDA Decisions

Reuters
·
Jul 16

Analysts Have Conflicting Sentiments on These Healthcare Companies: Gilead Sciences (GILD) and Johnson & Johnson (JNJ)

TIPRANKS
·
Jul 16

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 16

Gilead Bdrs in Brazil Undergo 6-for-1 Stock Split, Ratio Shifts to 1:12

Reuters
·
Jul 16

African Markets - Factors to Watch on July 15

Reuters
·
Jul 15

Congo Begins Trial of Gilead's Experimental Antiviral for Ebola Bundibugyo

Reuters
·
Jul 14

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 14

Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Quest Diagnostics (DGX) and Gilead Sciences (GILD)

TIPRANKS
·
Jul 13

Movement Alert|Gilead Sciences Rises 3.2% Overnight, HSBC Upgrades to Buy with Target Price Raised to $155

Market Focus
·
Jul 13